Outset Medical

OM

Market cap $246M

Overview Fund Activity

13.85 USD

+0.13

0.95%

At close Updated Sep 16, 4:00 PM EDT

Pre-market

After hours

13.85

0.00

0%

1 day

0.95%

5 days

-2.94%

1 month

1.32%

3 months

-32.31%

6 months

59.75%

Year to date

-21.08%

1 year

76.66%

5 years

-98.46%

10 years

-98.48%

About: Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.

Employees: 354

Healthcare Medical Devices

0

Funds holding %

of 7,463 funds

–

Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

486% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 7

116% more capital invested

Capital invested by funds: $163M [Q1] → $352M (+$189M) [Q2]

110% more call options, than puts

Call options by funds: $915K | Put options by funds: $436K

100% more funds holding in top 10

Funds holding in top 10: 1 [Q1] → 2 (+1) [Q2]

86% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 14

57% more funds holding

Funds holding: 60 [Q1] → 94 (+34) [Q2]

22.33% more ownership

Funds ownership: 83.23% [Q1] → 105.55% (+22.33%) [Q2]

See Fund Rankings

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target

$22

59% upside

Avg. target

$22

59% upside

High target

$22

59% upside

1 analyst rating

0 positive

0%

1 neutral

100%

0 negative

0%

RBC Capital

Shagun Singh

$22

Sector Perform

Reiterated

19 Aug 2025

See Analyst Rankings

Financial journalist opinion

Based on 4 articles about OM published over the past 30 days

Outset Medical, Inc. (OM) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Outset Medical, Inc. (NASDAQ:OM ) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 7:00 AM EDT Company Participants Leslie Trigg - President, CEO & Chairman Renee Gaeta - CFO, Principal Financial Officer & Principal Accounting Officer Conference Call Participants Steven Trainor Presentation Steven Trainor Good morning, everyone. I'm Steven Trainor, Vice President with Morgan Stanley.

Outset Medical, Inc. (OM) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

OUTSET MEDICAL ALERT: Bragar Eagel & Squire, P.C. is Investigating Outset Medical, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Outset Medical allegedly misled investors on Tablo's FDA status, sales risks, and growth prospects, lacking a reasonable basis for its positive outlook.

OUTSET MEDICAL ALERT: Bragar Eagel & Squire, P.C. is Investigating Outset Medical, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Northwest Kidney Centers and Outset Medical Announce Collaboration to Grow Home Hemodialysis

Collaboration to provide patients and caregivers access to innovative home dialysis with the Tablo® Hemodialysis System Collaboration to provide patients and caregivers access to innovative home dialysis with the Tablo® Hemodialysis System

Northwest Kidney Centers and Outset Medical Announce Collaboration to Grow Home Hemodialysis

Outset Medical to Present at the 23rd Annual Morgan Stanley Global Healthcare Conference

SAN JOSE, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that management will present at the 23rd annual Morgan Stanley Global Healthcare Conference on Wednesday, Sept. 10, 2025, at 7 a.m. Eastern time.

Outset Medical to Present at the 23rd Annual Morgan Stanley Global Healthcare Conference

Zacks Investment Research

After Plunging 26.8% in 4 Weeks, Here's Why the Trend Might Reverse for Outset Medical (OM)

Outset Medical (OM) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

After Plunging 26.8% in 4 Weeks, Here's Why the Trend Might Reverse for Outset Medical (OM)

Top 3 Health Care Stocks That Are Preparing To Pump This Month

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Top 3 Health Care Stocks That Are Preparing To Pump This Month

Outset Medical, Inc. (OM) Q2 2025 Earnings Call Transcript

Outset Medical, Inc. (NASDAQ:OM ) Q2 2025 Earnings Conference Call August 6, 2025 5:00 PM ET Company Participants James S. Mazzola - Head of Investor Relations Leslie L.

Outset Medical, Inc. (OM) Q2 2025 Earnings Call Transcript

Zacks Investment Research

Outset Medical, Inc. (OM) Reports Q2 Loss, Beats Revenue Estimates

Outset Medical, Inc. (OM) came out with a quarterly loss of $0.84 per share versus the Zacks Consensus Estimate of a loss of $1.76. This compares to a loss of $7.05 per share a year ago.

Outset Medical, Inc. (OM) Reports Q2 Loss, Beats Revenue Estimates

Outset Medical Second-Quarter Results Demonstrate Continued Momentum, Punctuated by Strong Revenue Growth, Console Placements and Utilization

Company raises 2025 revenue guidance to a range of $122 million to $126 million Company raises 2025 revenue guidance to a range of $122 million to $126 million

Outset Medical Second-Quarter Results Demonstrate Continued Momentum, Punctuated by Strong Revenue Growth, Console Placements and Utilization

Outset Medical Names First Chief Nursing Officer

SAN JOSE, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced Brittni McGill has been named to the newly created role of Chief Nursing Officer where she will apply her extensive nurse executive leadership experience to help increase strategic outreach and clinical program innovation designed to empower nurses and nurse leaders and elevate care.

Outset Medical Names First Chief Nursing Officer

See News Rankings

Charts implemented using Lightweight Charts™